title: Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
abstract: OBJECTIVE
  Adipocyte fatty acid-binding protein (A-FABP) is abundantly expressed in adipocytes and plays a role in glucose homeostasis in experimental animals. We have previously shown that circulating A-FABP levels are associated with the metabolic syndrome, which confers an increased risk of type 2 diabetes. Here we investigated whether serum A-FABP levels could predict the development of diabetes in a 10-year prospective study.
  
  
  METHODS
  Baseline serum A-FABP levels were measured with an enzyme-linked immunosorbent assay in 544 nondiabetic subjects, recruited from the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort, who were followed prospectively to assess the development of type 2 diabetes. The role of A-FABP in predicting the development of type 2 diabetes over 10 years was investigated using Cox regression analysis.
  
  
  RESULTS
  At baseline, serum sex-adjusted A-FABP levels were higher in subjects with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) (P < 0.00001 versus normal glucose tolerance) and correlated positively with adverse cardiometabolic risk factors. Over 10 years, 96 subjects had developed type 2 diabetes. High baseline A-FABP was predictive of type 2 diabetes, independent of obesity, insulin resistance, or glycemic indexes (relative risk [RR] 2.25 [95% CI 1.40-3.65]; P = 0.001; above versus below sex-specific median). High A-FABP levels remained an independent predictor of type 2 diabetes in the high-risk IGT/IFG subgroup (adjusted RR 1.87 [1.12-3.15]; P = 0.018).
  
  
  CONCLUSIONS
  Serum A-FABP was associated with glucose dysregulation and predicted the development of type 2 diabetes in a Chinese cohort.
authors.affiliation: Department of Medicine, University of Hong Kong, Hong Kong, China.
authors.forename: Annette W K
authors.initials: AW
authors.lastname: Tso
authors.forename: Aimin
authors.initials: A
authors.lastname: Xu
authors.forename: Pak C
authors.initials: PC
authors.lastname: Sham
authors.forename: Nelson M S
authors.initials: NM
authors.lastname: Wat
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
authors.forename: Carol H Y
authors.initials: CH
authors.lastname: Fong
authors.forename: Bernard M Y
authors.initials: BM
authors.lastname: Cheung
authors.forename: Edward D
authors.initials: ED
authors.lastname: Janus
authors.forename: Karen S L
authors.initials: KS
authors.lastname: Lam
mesh_terms: D017667:Adipocytes / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology*; D050556:Fatty Acid-Binding Proteins / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012016:Reference Values
chemical_list: D050556:Fatty Acid-Binding Proteins